Steve Tejiram

As Florida’s Senior Director of Business Development & Patient Care, Steve Tejiram brings both personal experience and professional dedication to his role at ASAP Specialty Pharmacy. Diagnosed with severe hemophilia A shortly after immigrating from Guyana at age 14, his life has been defined by resilience, advocacy, and innovation in treatment. In 2018, Steve became one of the first patients in the United States to receive gene therapy for hemophilia A through a clinical trial, an advancement that greatly improved his quality of life and allowed him to engage in activities once out of reach. While he emphasizes that gene therapy is an improvement rather than a cure, it strengthened his resolve to expand access to cutting-edge therapies for others.

For more than two decades, Steve has been a recognized leader in the bleeding disorders community, serving as Vice President of the Florida Hemophilia Association and continuing his advocacy as an Ambassador for the Hemophilia Federation of America and HOPE for Hemophilia. His work at the state and federal levels focuses on increasing treatment access, educating patients, and building stronger support networks. With the encouragement of his family, including a daughter with mild Hemophilia A who was inspired to pursue a career in hematology, Steve leverages his unique blend of personal insight and professional expertise to ensure patients and families receive compassionate, informed, and effective care.